#0 (0%) - prexainc.com
Title: Prexa Pharmaceuticals - Developing compounds to safely enhance dopamine
Description: Exploring the benefits of dopamine reuptake inhibition to treat ADHD, depression, Parkinson's disease and other CNS diseases
Keywords:dopamine, triple reuptake inhibitor, reuptake inhibitor, neurotransmitter, norepinephrine, serotonin, ADHD, depression, Parkinsons disease, CNS, monoamine, transporter, PRX-12251, small molecule Scott Reines, Ev Graham, Charlie Cohen, Jason Fisherman, Shire, Brian Piper, Tom Needham, Eric Bednarksi, Boston, biotechnology, development